Well LKE is a high risk investment and the risk is for the upside and the downside. If Hazem and Novonix testing of the purity and efficacy of the LCE is 99.9% and above then the product is well qualified and will be in great demand. The other big hurdle is financing and if the BOD can come up with a good working model we will be rewarded. The problem is it will then be much more costly to invest/get set. So at present it is a punt on how it is managed by the BOD. GLTAH
Well LKE is a high risk investment and the risk is for the...
Add LKE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.40M | |||
| Open | High | Low | Value | Volume |
| 3.7¢ | 3.9¢ | 3.7¢ | $529.3K | 13.91M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 2362455 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 1150000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| LKE (ASX) Chart |